In fact, it appears that chronic trygliceride accumulation in the liver creates a stress condition that damages hepatocytes, leading to increased transcription and secretion of FGF21 [70], suggesting it as a potential biomarker for metabolic disorders [17]. Here, FGF21 is linked to metabolic disease.